Close Menu

Diagnostics Business, Policy & Funding

Breaking news on Diagnostics business, policy & funding.

Takeda said that the tool evaluates risk for developing complications associated with Crohn's disease and helps support personalized clinical decision-making.

The seven-year grant renews funding for the Antibacterial Resistance Leadership Group, led by Duke University and UCSF, with $15 million in 2020.

Tempus said that Akesogen's lab provides a range of testing services, including for inherited risk of cancer, microbiome profiling, whole-genome genotyping, and more.

The new guidance concerns the technical assessment of certain devices under the IVDR, which is slated to come into force in May 2022.

The firm said it is turbocharging the lateral flow format with sensitivity and cost suitable for over-the-counter STI testing.